Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2018 | Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development | Yun-Chieh Sung; Ya-Chi Liu; Po-Han Chao; Chih-Chun Chang; Pei-Ru Jin; Ts-Ting Lin; Ja-An Lin; HUI-TENG CHENG ; Jane Wang; Charles P. Lai; Ling-Hsuan Chen; Anthony Y. Wu; Ting-Lun Ho; Tsaiyu Chiang; Dong-Yu Gao; Dan G. Duda; Yunching Chen | Theranostics | 68 | 60 |